Babak Kateb

Summary

Publications

  1. ncbi Internalization of MWCNTs by microglia: possible application in immunotherapy of brain tumors
    Babak Kateb
    Brain Tumor Program, Department of Neurosurgery, 1500 East Duarte Road, Duarte, CA 91010, USA
    Neuroimage 37:S9-17. 2007
  2. ncbi Sniffing out cancer using the JPL electronic nose: a pilot study of a novel approach to detection and differentiation of brain cancer
    Babak Kateb
    International Brain Mapping and Intraoperative Surgical Planning Society IBMISPS org, USA
    Neuroimage 47:T5-9. 2009
  3. ncbi Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Babak Kateb
    Brain Mapping Foundation, West Hollywood, CA 90046, USA
    Neuroimage 54:S106-24. 2011
  4. ncbi Multi-walled carbon nanotube (MWCNT) synthesis, preparation, labeling, and functionalization
    Babak Kateb
    Brain Mapping Foundation and International Brain Mapping and Intraoperative Surgical Planning Society IBMISPS, West Hollywood, CA, USA
    Methods Mol Biol 651:307-17. 2010
  5. ncbi Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model
    Michelle VanHandel
    Division of Neurosurgery, City of Hope Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
    J Neuroimmunol 208:3-9. 2009
  6. ncbi Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma
    David Lin
    Division of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
    Neuroimage 37:S18-26. 2007

Collaborators

Detail Information

Publications6

  1. ncbi Internalization of MWCNTs by microglia: possible application in immunotherapy of brain tumors
    Babak Kateb
    Brain Tumor Program, Department of Neurosurgery, 1500 East Duarte Road, Duarte, CA 91010, USA
    Neuroimage 37:S9-17. 2007
    ..This study suggests MWCNTs could be used as a novel, non-toxic, and biodegradable nano-vehicles for targeted therapy in brain cancers. Further studies are needed to demonstrate the full capacity of MWCNTs as nanovectors...
  2. ncbi Sniffing out cancer using the JPL electronic nose: a pilot study of a novel approach to detection and differentiation of brain cancer
    Babak Kateb
    International Brain Mapping and Intraoperative Surgical Planning Society IBMISPS org, USA
    Neuroimage 47:T5-9. 2009
    ....
  3. ncbi Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
    Babak Kateb
    Brain Mapping Foundation, West Hollywood, CA 90046, USA
    Neuroimage 54:S106-24. 2011
    ....
  4. ncbi Multi-walled carbon nanotube (MWCNT) synthesis, preparation, labeling, and functionalization
    Babak Kateb
    Brain Mapping Foundation and International Brain Mapping and Intraoperative Surgical Planning Society IBMISPS, West Hollywood, CA, USA
    Methods Mol Biol 651:307-17. 2010
    ..We used this technique to manipulate microglia as part of a novel application for the brain cancer immunotherapy. Our published data show this is a promising technique for labeling, and gene and drug delivery into microglia...
  5. ncbi Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model
    Michelle VanHandel
    Division of Neurosurgery, City of Hope Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
    J Neuroimmunol 208:3-9. 2009
    ..This study suggests that MWCNTs could potentially be used as a novel and non-toxic vehicle for targeting MP in brain tumors...
  6. ncbi Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma
    David Lin
    Division of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA
    Neuroimage 37:S18-26. 2007
    ..We estimate that NSC-mediated therapy would eradicate 70-90% of the primary tumor mass and the majority of invasive tumor foci. Our method may serve as a model for optimizing the efficacy of NSC-based glioma therapy...